Center for Law and Biosciences, Stanford University, Stanford, California.
CRISPR J. 2019 Oct;2(5):253-265. doi: 10.1089/crispr.2019.0038.
This article assesses human germline genome editing (GGE). It argues that such editing is not inherently unethical, largely because of the fuzzy nature of "The Human Germline Genome" and its constant changes, often caused by humans. It further argues that GGE is unlikely to be very useful, at least in the near term to mid term. Other methods, such as preimplantation genetic testing and somatic cell gene therapy, are likely to be safer and more effective for dealing with avoiding single gene diseases. The main exceptions are rare couples wherein both have the same recessive condition or one has two copies of an allele causing a dominant condition. Although GGE should have advantages in dealing with multigenic or enhancement applications, our genomic knowledge is inadequate to support more than a few such applications for many years.
本文评估了人类生殖系基因组编辑(GGE)。它认为这种编辑本身并不是不道德的,主要是因为“人类生殖系基因组”的模糊性质及其经常由人类引起的不断变化。它进一步认为,GGE 不太可能非常有用,至少在近期到中期内是这样。其他方法,如胚胎植入前遗传检测和体细胞基因治疗,对于避免单基因疾病可能更安全、更有效。主要的例外情况是罕见的夫妇,他们双方都有相同的隐性疾病,或者一方有两个等位基因拷贝导致显性疾病。尽管 GGE 在处理多基因或增强应用方面应该具有优势,但我们的基因组知识不足以支持多年来的少数此类应用。